Search Results 391-400 of 17275 for Cyclophosphamide

  1. CYP2C19 Genotype Predictor of Gastric Acid Suppression - Mayo Clinic

    Use of drugs that interfere with CYP2C19 metabolism: Diazepam, phenytoin, amitriptyline, clomipramine, clopidogrel Cyclophosphamide, progesterone, fluoxetine, ...

  2. Cholangiocarcinoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...

  3. Oncology (Medical) - Clinical trials

    The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...

  4. Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation - Mayo Clinic

    Planned umbilical cord blood transplant or planned to receive posttransplant cyclophosphamide, in-vivo or ex-vivo T cell-depleted hematopoietic stem cells (HSCs) ...

  5. Publications - Hani M. Babiker, M.D. - Mayo Clinic

    Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutation. Anticancer ...

  6. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

    Subjects who received any approved anticancer chemotherapy within 21 days of first dose (exception cyclophosphamide as NMA conditioning). Subjects with ...

  7. Clinical trials - Oncology (Medical)

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian ...

  8. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Lymphotoxic chemotherapeutic agents (e.g., cyclophosphamide, ifosfamide, bendamustine) 2 weeks prior to unstimulated leukapheresis. Experimental agents ...

  9. Epirubicin (intravenous route) - Side effects & uses - Mayo Clinic

    Epirubicin injection is used together with other cancer medicines to treat breast cancer in patients who have had surgery to remove the tumor. Epirubicin ...

  10. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    Treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide ...